You can be contagious from a few days up to two weeks or more, depending on which virus is causing your stomach flu (gastroenteritis).

The overall odds of surviving a cardiac arrest in the U.S. could vary by as much as 42 percent between randomly selected hospitals.1  Research has found that poor quality CPR should be considered a preventable harm, and timely delivery of high-quality CPR is the greatest determinant of survival from cardiac arrest.2 Unfortunately, even with trained professionals, poor quality CPR is common.3 In response, the American Heart Association, the world’s leading voluntary health organization devoted to fighting cardiovascular disease and stroke, is addressing the need for alternative training models to support and develop highly skilled healthcare professionals.

Houston-based foundations and organizations, along with donors from across the nation, have matched a $10 million challenge grant offered by the Richard M. Schulze Family Foundation to help build an American Cancer Society Hope Lodge facility and to fund its operating endowment.

The National Colorectal Cancer Roundtable (NCCRT), an organization co-founded by the American Cancer Society and the Centers for Disease Control and Prevention, recognized seven honorees with the 80% by 2018 National Achievement Award, a national honor recognizing leadership in the ongoing effort to increase colorectal cancer screening rates across the Unites States.

In findings presented to the American Society of Hematology, Mayo Clinic researchers found that using emojis instead of traditional emotional scales were helpful in assessing patients’ physical, emotional and overall quality of life. Researchers found that using iPhones and Apple Watches were favored by patients, and the technology helped collect study data accurately and efficiently. The study, created using Apple’s ResearchKit framework, showed that Apple Watch provides objective, continuous activity data that correlates with established cancer patient-reported outcomes.

The investigational Zika purified inactivated virus (ZPIV) vaccine was well-tolerated and induced an immune response in participants, according to initial results from three Phase 1 clinical trials. Scientists at the Walter Reed Army Institute of Research (WRAIR), part of the U.S. Department of Defense, are developing the vaccine as well as leading one of the trials. WRAIR also is co-funding the trials together with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).